IN THE NEWS | Oceanit Progresses Towards FDA EUA Submission
Oceanit has been hard at work to develop and perfect the ASSURE-19 rapid test for submission to the U.S. FDA for emergency use authorization. Hawaii News Now reconnected with Dr. Patrick Sullivan last week to speak about the huge effort being made and the challenges being overcome as ASSURE-19 moves ever-closer to authorization.
COVID-19 Cases Still Growing, Links to Academic Papers
On October 24th, the United States tracked 78,702 new infections of Covid-19, a +32% 14-day change. The same day, 871 new COVID-related deaths were counted, this represents a +15% 14-day change. Click to find links to important academic papers from experts at Harvard, the University of Colorado at Boulder, Yale University, and more.
Press Release | AUG 20: NIH Funding and Moving to Trials
Oceanit Laboratories’ ASSURE-19 rapid point-of-need COVID-19 test has been selected for continued support by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to fill the nation’s critical need for rapid, simple, and affordable COVID-19 testing.